Morphologic Studies of the Retina in a New Diabetic Model; SHR/N:Mcc-cp Rat

Yonsei Medical Journal

Volumn 39, Issue 5, 1998, Pages 453-462

  Kim, Soon Hyun ^a   Chu, Young Kwang ^a   Kwon, Oh Woong ^a   McCune, Sylvia A ^b   Davidorf, Frederick H ^b  

^a Yonsei University College of Medicine   (South Korea)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Diabetic retinopathy; SHR N:Mcc cp rat

Indexed keywords

ANIMAL; ARTICLE; DIABETIC RETINOPATHY; DISEASE MODEL; FEMALE; GENETICS; HYBRIDIZATION; MALE; PATHOLOGY; RAT; RAT STRAIN; RETINA; RETINA DEGENERATION; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; FEMALE; HYBRIDIZATION, GENETIC; MALE; RATS; RATS, INBRED SHR; RATS, INBRED STRAINS; RETINA; RETINAL DEGENERATION;

EID: 0032192823     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1998.39.5.453     Document Type: Article

References (53)

1. Arison RN, Glaccio EI, Glizer MS, Cassaro AB, Pruss MP: Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 16: 51-56, 1967
2. Ashton N: Pathogenesis of diabetic retinopathy. In Diabetic Retinopathy. New York, Thieme-Stratton Inc, 1983, 85-106
3. Babel J, Leuenberger P: A long term study on the ocular lesions in streptozotocin diabetic rats. Albrecht Von Graefes Arch Ophthal 189: 191-209, 1974
4. Brinchman-Hansen O, Dahl-Jorgensen K, Hanssen KF: Effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol 100: 644-653, 1985
5. Bruns RR, Palade GG: Studies on blood capillaries: I. General organization of blood capillaries in muscle. J Cell Biol 37: 244-248, 1968
6. Cameron DP, Amherdt M, Leuenberger P, Orci L, Stauffacher W: Microvascular alterations in chronically streptozotocin-diabetic rats. Adv Metab Disorders 2(Suppl): 257-269, 1973
7. Cameron DP, Leuenberger P, Amherdt M, Mira F, Orci L, Stauffacher W: Microvascular lesions including retinal aneurysms in chronic experimental diabetes (streptozotocin). Eur J Clin Invest 1: 365-369, 1971
8. Chase HP, Jackson WE, Hoops SL: Glucose control in the renal and retinal complications of insulin-dependent diabetes. JAMA 261: 1155-1160, 1989
9. Cogan DG, Kuwabara T: The mural cell in perspective. Arch Ophthalmol 78: 133-139, 1967
10. Cogan DG, Toussaint D, Kuwabara T: Retinal vascular patterns: IV. Diabetic retinopathy. Arch Ophthalmol 66: 366-375, 1961
11. Cohen AM, Michealson IC, Yanko L: Retinopathy in rats with disturbed carbohydrate metabolism following a high sucrose diet. Am J Ophthalmol 73: 863-869, 1972
12. Crocker DJ, Murad TM, Geer JC: Role of the pericyte in wound healing:an ultrastructural study. Exp Mol Pathol 13: 51-62, 1970
13. Das A, Frank RN, Zhang NL: Increase in collagen type IV and laminin galactose-induced retinal capillary basement membrane thickening - Prevention by an aldose reductase inhibitor. Exp Eye Res 50: 269-280, 1990
14. de Venecia G, Davis M, Engerman R: Clicopathologic correlations in diabetic retinopathy. Arch Ophthalmol 94; 1766-1773, 1976
15. Early Treatment Diabetic Retinopathy Study Report Number 9: Early photocoagulation of diabetic retinopathy. Ophthalmology 98: 766-785, 1991
16. Edelman GM, Thiery JP: The Cell in Contact: Adhesions and Junctions as Morphogenetic Determinants. New York, John Wiley & Sons, 1985, 67-92
17. Engerman RL, Kern TS: Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33: 97-100, 1984
18. Frank RN: On the pathogenesis of diabetic retinopathy. Ophthalmology 91: 626-634, 1984
19. Grunwald JE, Riva CE, Martin DB: Effect of insulin-induced decrease in blood glucose on the diabetic retinal circulation. Ophthalmology 94: 1614-1620, 1987
20. Hogan MJ, Feeney L: The ultrastructre of the retinal vessels: II. The small vessels. J Ultrastruc Res 9: 29-37, 1963
21. Kahn HA, Hiller R: Blindness caused by diabetic retinopathy. Am J Ophthalmol 78: 58-67, 1974
22. Kador PF, Akagi Y, Terubayashi H, Wyman M, Kinoshita JH: Prevention of pericyte ghost formation in retinal capillaries galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol 106: 1099-1102, 1988
23. Klein R, Klein BEK, Moss SE: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526, 1984a
24. Klein R, Klein BEK, Moss SE: The Wisconsin Epidemiologie Study of Diabetic Retinopahty. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527-532, 1984b
25. Kohner EM, Henkind P: Correlation fo fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 69: 403-411, 1970
26. Kojima K, Matsubara H, Harada T, Mizuno K, Suzuki M, Hotta N, Kakura H, Sakamoto N: Effect of the aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats. Jpn J Ophthal 29: 99-109, 1985
27. Krolewski AS, Canessa M, Warram JH: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318: 140-145, 1988
28. Kuwabara T, Cogan DG:Retinal vascular patterns: VI. Mural cells of retinal capillaries. Arch Ophthalmol 69: 492-501, 1963
29. Leeson TS:Rat retinal blood vessels.Can J Ophthalmol 14: 21-27, 1979
30. Leuenberger P, Beauchemin ML, Babel J: Experimental diabetic retinopathy. Arch Ophthal (Paris) 34: 289-302, 1974
31. Leuenberger P, Cameron D, Stauffacher W, Renold AF, Babel J: Ocular lesions in rats rendered chronically diabetic with streptozotocin. Ophthal Res 2: 189-204, 1971
32. McCune SA, Baker PB, Stills HF: SHHF/Mcc-cp rat: model of obesity, non-insulin-dependent diabetes, and congestive heart failure. ILAR News 32: 23-27, 1990
33. McCune SA, Jenkins JE, Stills HF: Renal and heart function in the SHHR/N-Mcc-cp rat. Frontiers in diabetes research. Lessens from animal diabetes III. In Shafrir E, ed. Smith-Gordon. Viii. 1, 1991, 397-401
34. McCune SA, Jurin RR, Hansen T, Dunn RB, Chedid A, Fox E, Summers B, WeiT T: SHR: N-Mcc-cp rat substrain: General characteristics, congestive heart failure syndrome. In Hansen CT a'd Michaelsi OE, IV, eds. New Models of Genetically Obese Rats for Studies in Diabetes, Heart disease, and Complication of Obesity. MD, Bethesda, National Institutes of Health, 1988, 95-103
35. Michaelis OE. IV, Carswell N, Hansen CT, Canary JJ, Kimmel PL: A new genetic model of non-insulin dependent diabetes and hypertension: the spontaneous hypertensive/NIH corpulent fat. In "Frontiers in Diabetes Research. Lessons from Animal Diabetes II". London, John Libbey, 1988, 257-264
36. Michaelis OE. IV, Patrick DH, Hansen CT, Canary JJ, Werner RM, Carswell N: Spontaneous hypertensive/ NIH-copulent rat. Animal model of human disease, insulin-dependant diabetes mellitus(type II). Am J Pathol 123: 398-400, 1986
37. Moloney JBM, Drury MI: The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 93: 745-756, 1982
38. Orlidge A, D'Amore PA: Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105: 1455-1461, 1987
39. Parachristodoulou D, Heath H, Kang SS: The development of retinopathy in sucrose-fed and streptozotocin-diabetic rats. Diabetologia 32: 367-374, 1976
40. Phelps RL, Sakol P, Metzger BE: Changes in diabetic retinopathy during pregnancy: Correlations wih regulation of hyperglycemia. Arch Ophthalmol 104: 1806-1810, 1986.
41. Robinson WG, Nagata M, Laver N: Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci 30: 2285-2292, 1989
42. Rosenman E, Yanko L, Cohen AM: Comparativestudy of pathology of sucrose-induced diabetes in the rat and adult onset diabetes in man. Isr J Med Sci 11: 753-761, 1975
43. Serup L: Influence of pregnancy on diabetic retinopathy. Acta Endocrinol 277: 122-124, 1986
44. Sima AAF, Chakrabarti S, Garcia-Salinas R, Basu PK: The BB-rat-an authentic model of human diabetic retinopathy. Curr Eye Res 4: 1087-1092, 1985
45. Sima AAF, Garsia-Salinas R, Basu PK: The BB-Wistar rat: An experimental model for the study of diabetic retinopathy. Metabolism 32: 136-140, 1983
46. Sims DE: The pericyte-a review. Tissue Cell 18: 153-156, 1986
47. Skovberg F, Neilson AV, Larkuitzen E: Diameters of the retinal vessels in diabetic and normal subjects. Diabetes 18: 292-298, 1969
48. Sosula L, Beaumont P, Hollows F, Jonson K: Dilatation and endomelial proliferation of retinal capilleries in streptozotocin-diabetic rats: Quantitative electron microscopy. Invest Ophthal 11: 926-935, 1972
49. Stem MP, Patterson JK, Haffner SM: Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey. JAMA 262: 360-364, 1989
50. The Kroc Collaborative Study Group: Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 311: 365-372, 1984
51. von Sallmann L, Grimes P: Histopathologic changes in the eyes and kidneys of rats with long term streptozotocin diabetes. In Bellows J, ed. Contemporary ophthalmology honoring Sir Stewart Duke-Elder. Baltimore, Wilkin and Wilkin Co., 1972, 502-509
52. Watanabe R: Histological studies of the retina of rats with streptozotocin-induced diabetes. Acta Soc Ophthal Jap 77: 605-614, 1973
53. Yanoff M: Ocular pathology of diabetes. Am J Ophthalmol 67: 21-38, 1969